Peru’s medicines and medical devices regulator
Peru’s medicines and medical devices regulator
Ministerial Resolution 929-2026/MINSA updates Peru’s national essential medicines formulary with eight HIV and hepatitis products, including a once-daily pediatric HIV tablet for about 500 children and options for more than …
A bill backed by Peru’s health ministry would make clinics calculate drug copayments from Digemid market prices, not the Kairos catalogue. If it passes, expect clinics to seek the margin …
Peru’s Digemid has approved South Korean regenerative medicine company L&C Bio’s Re2O, an injectable based on human skin extracellular matrix, for commercialisation; the company plans to use Peru as a …
You must be logged in to post a comment.